Strategic collaboration combines KYBORA’s global biopharma network with ACA Pharma’s 30–90 day Macau registration model to expedite access for rare disease and pediatric therapies in China. KYBORA and ACA Pharma…
Reach Out for Our Complimentary Global Biotech Licensing Readiness Assessment In our complimentary one-hour consultation, our team of seasoned professionals…
Developing groundbreaking therapies, commercializing products, and/or finding the right partners are all essential activities for successful biotech companies. These tasks…
The biotech industry is characterized by intense competition stemming from scientific breakthroughs, innovative therapies, and cutting-edge technologies. Biotech CEOs encounter…
In the intricate landscape of biotechnology, the path to introducing innovative products comes with challenges that require strategic expertise. Overcoming…
Biotech research and development serve as the bedrock of groundbreaking advancements, but the journey often demands substantial financial backing. CEOs…
